Bio-Rad Launches New Chromatography Column Packs
Bio-Rad’s EconoFit Chromatography Column Packs support resin screening experiments in the development of protein purification workflows.
Bio-Rad Laboratories has launched its EconoFit Low-Pressure Prepacked Chromatography Column Packs. The EconoFit columns are designed for resin screening, allowing customers that are developing protein purification workflows to select the optimal chemistry for different targets.
The columns offer various resins in a prepacked format, including mixed-mode, cation, and anion exchange resin columns, as well as a pack designed for polyhistidine protein purification. According to a June 28, 2022 press release, they are fully compatible with Bio-Rad’s next-generation chromatography systems in addition to other commonly used chromatography systems. The columns are available in 1 mL and 5 mL sizes.
“Similar resins can give different results for different target molecules, and with Bio-Rad’s EconoFit Column Packs our customers can easily perform resin scouting to identify the one [that] yields the best outcome for their chromatography application,” said Ertan Ozyamak, global product manager for lab-scale chromatography products, Bio-Rad, in the press release. “Our columns deliver run-to-run uniformity to support preparative scale purifications and/or method development for new target proteins, as well as to improve existing workflows.”
Source: Bio-Rad
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Mechanistic Hypothesis of Toxicity: Driving Decision Making in Preclinical Translation
July 16th 2025Mechanistic toxicity hypothesis is essential in guiding decision-making and predicting toxicities during the preclinical stages of drug development. The authors highlight the growing importance of integrating advanced technologies like mass spectrometry imaging into toxicology to enhance preclinical translation, foster innovation in therapeutic development, and ultimately improve drug safety and efficacy.
